Evolution of induction chemotherapy for non-small cell lung cancer over the last 30 years: A surgical appraisal.
| Author | |
|---|---|
| Abstract | :
Induction chemotherapy (ICT) is supposed to reduce the risk of micrometastatic progression and improve resectability of non-small cell lung cancer (NSCLC). However, best indications for ICT strategy remain unclear in published meta-analyses. Based on this observation, an evaluation of daily practice is of importance. Therefore, we reviewed indications and efficacy time trends in our 30-year series. |
| Year of Publication | :
2015
|
| Journal | :
Thoracic cancer
|
| Volume | :
6
|
| Issue | :
6
|
| Number of Pages | :
731-40
|
| ISSN Number | :
1759-7706
|
| URL | :
https://doi.org/10.1111/1759-7714.12250
|
| DOI | :
10.1111/1759-7714.12250
|
| Short Title | :
Thorac Cancer
|
| Download citation |